Institutional investors purchased a net $1.2 million shares of SGEN during the quarter ended September 2013, and now own 106.16% of the total float, a percentage that is typical for companies in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
BAILLIE GIFFORD & CO. Bought 3.6 Million shares of Seattle Genetics Inc
BAKER BROS. ADVISORS LP Bought 1.0 Million shares of Seattle Genetics Inc